AAPL   322.31 (+1.37%)
MSFT   182.59 (-0.36%)
FB   229.71 (+2.05%)
GOOGL   1,431.97 (-0.11%)
AMZN   2,467.55 (+1.03%)
NVDA   351.12 (-1.10%)
CGC   16.62 (-4.32%)
BABA   206.47 (-0.44%)
MU   46.51 (-2.92%)
GE   6.69 (+1.67%)
TSLA   887.88 (+6.33%)
T   31.00 (+0.45%)
F   5.83 (+2.10%)
GILD   75.66 (-2.79%)
DIS   119.14 (+1.57%)
NFLX   424.62 (+1.17%)
BA   151.28 (+3.72%)
AAPL   322.31 (+1.37%)
MSFT   182.59 (-0.36%)
FB   229.71 (+2.05%)
GOOGL   1,431.97 (-0.11%)
AMZN   2,467.55 (+1.03%)
NVDA   351.12 (-1.10%)
CGC   16.62 (-4.32%)
BABA   206.47 (-0.44%)
MU   46.51 (-2.92%)
GE   6.69 (+1.67%)
TSLA   887.88 (+6.33%)
T   31.00 (+0.45%)
F   5.83 (+2.10%)
GILD   75.66 (-2.79%)
DIS   119.14 (+1.57%)
NFLX   424.62 (+1.17%)
BA   151.28 (+3.72%)
AAPL   322.31 (+1.37%)
MSFT   182.59 (-0.36%)
FB   229.71 (+2.05%)
GOOGL   1,431.97 (-0.11%)
AMZN   2,467.55 (+1.03%)
NVDA   351.12 (-1.10%)
CGC   16.62 (-4.32%)
BABA   206.47 (-0.44%)
MU   46.51 (-2.92%)
GE   6.69 (+1.67%)
TSLA   887.88 (+6.33%)
T   31.00 (+0.45%)
F   5.83 (+2.10%)
GILD   75.66 (-2.79%)
DIS   119.14 (+1.57%)
NFLX   424.62 (+1.17%)
BA   151.28 (+3.72%)
AAPL   322.31 (+1.37%)
MSFT   182.59 (-0.36%)
FB   229.71 (+2.05%)
GOOGL   1,431.97 (-0.11%)
AMZN   2,467.55 (+1.03%)
NVDA   351.12 (-1.10%)
CGC   16.62 (-4.32%)
BABA   206.47 (-0.44%)
MU   46.51 (-2.92%)
GE   6.69 (+1.67%)
TSLA   887.88 (+6.33%)
T   31.00 (+0.45%)
F   5.83 (+2.10%)
GILD   75.66 (-2.79%)
DIS   119.14 (+1.57%)
NFLX   424.62 (+1.17%)
BA   151.28 (+3.72%)
Log in

EPA:SANSanofi News Headlines

€88.69
+1.16 (+1.33 %)
(As of 06/1/2020 03:12 PM ET)
Add
Compare
Today's Range
€88.16
Now: €88.69
€89.56
50-Day Range
€82.00
MA: €87.60
€93.40
52-Week Range
€63.09
Now: €88.69
€92.97
Volume1.56 million shs
Average Volume3.05 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Sanofi (EPA SAN) News Headlines

Source:
DateHeadline
Sanofi (EPA:SAN) PT Set at €103.00 by JPMorgan Chase & Co.Sanofi (EPA:SAN) PT Set at €103.00 by JPMorgan Chase & Co.
www.americanbankingnews.com - June 1 at 6:57 AM
Sanofi announces closing of Regeneron stock sale Paris Stock Exchange:SAN - GlobeNewswireSanofi announces closing of Regeneron stock sale Paris Stock Exchange:SAN - GlobeNewswire
www.globenewswire.com - May 29 at 6:05 PM
Sanofi announces closing of Regeneron stock saleSanofi announces closing of Regeneron stock sale
finance.yahoo.com - May 29 at 6:05 PM
Sanofi halts enrollment in studies of malaria drug in COVID-19Sanofi halts enrollment in studies of malaria drug in COVID-19
seekingalpha.com - May 29 at 1:04 PM
Influenza Vaccine Market Clinical Research Analysis 2020 to 2026: Sanofi, Altimmune, BionVax, FluGen, Folia BiotechInfluenza Vaccine Market Clinical Research Analysis 2020 to 2026: Sanofi, Altimmune, BionVax, FluGen, Folia Biotech
www.marketwatch.com - May 29 at 1:04 PM
Regeneron and Sanofis cemiplimab shows benefit in type of skin cancerRegeneron and Sanofi's cemiplimab shows benefit in type of skin cancer
seekingalpha.com - May 29 at 1:04 PM
Exclusive: Sanofi stops enrolling COVID-19 patients in hydroxychloroquine trials amid safety concernsExclusive: Sanofi stops enrolling COVID-19 patients in hydroxychloroquine trials amid safety concerns
www.reuters.com - May 29 at 1:04 PM
Sanofi suspends recruitment for coronavirus clinical trials testing hydroxychloroquineSanofi suspends recruitment for coronavirus clinical trials testing hydroxychloroquine
www.cnbc.com - May 29 at 1:04 PM
Sanofi names new leaders to Executive Committee Paris Stock Exchange:SAN - GlobeNewswireSanofi names new leaders to Executive Committee Paris Stock Exchange:SAN - GlobeNewswire
www.globenewswire.com - May 29 at 8:03 AM
Sanofi’s Board of Directors notes the resignation of Emmanuel Babeau and coopts Gilles Schnepp as Independent DirectorSanofi’s Board of Directors notes the resignation of Emmanuel Babeau and coopts Gilles Schnepp as Independent Director
finance.yahoo.com - May 28 at 2:39 PM
U.S. FDA finds high levels of carcinogen in diabetes drug metforminU.S. FDA finds high levels of carcinogen in diabetes drug metformin
finance.yahoo.com - May 27 at 6:21 PM
Sanofi to Sell Regeneron Shares Worth $11.1 Billion to Fund Overhaul - The Wall Street JournalSanofi to Sell Regeneron Shares Worth $11.1 Billion to Fund Overhaul - The Wall Street Journal
www.wsj.com - May 27 at 1:21 PM
Sanofi's Dupixent Gets FDA Approval for Eczema in ChildrenSanofi's Dupixent Gets FDA Approval for Eczema in Children
finance.yahoo.com - May 27 at 1:21 PM
Regeneron Announces Pricing Of Secondary Offering Of Its Stock Held By Sanofi At $515.00/shr - NasdaqRegeneron Announces Pricing Of Secondary Offering Of Its Stock Held By Sanofi At $515.00/shr - Nasdaq
www.nasdaq.com - May 27 at 8:16 AM
Regeneron to buy back $5 billion in stock as Sanofi sells part of its stake - MarketWatchRegeneron to buy back $5 billion in stock as Sanofi sells part of its stake - MarketWatch
www.marketwatch.com - May 26 at 5:01 PM
Sanofi Cashes In On Massive Regeneron Stock Run-UpSanofi Cashes In On Massive Regeneron Stock Run-Up
www.thestreet.com - May 26 at 12:00 PM
S&P 500, Dow Jones Today Top Resistance As Covid-19 Vaccine Race Heats UpS&P 500, Dow Jones Today Top Resistance As Covid-19 Vaccine Race Heats Up
finance.yahoo.com - May 26 at 12:00 PM
Regeneron Is Finally Free of Sanofi. Why That’s Good for Its Stock.Regeneron Is Finally Free of Sanofi. Why That’s Good for Its Stock.
finance.yahoo.com - May 26 at 12:00 PM
Regeneron (REGN) to Buy Back Part of Its Stake Held by SanofiRegeneron (REGN) to Buy Back Part of Its Stake Held by Sanofi
finance.yahoo.com - May 26 at 12:00 PM
The Zacks Analyst Blog Highlights: Moderna, Pfizer, BioNTech, Sanofi and GlaxoSmithKlineThe Zacks Analyst Blog Highlights: Moderna, Pfizer, BioNTech, Sanofi and GlaxoSmithKline
finance.yahoo.com - May 26 at 12:00 PM
Novavax expects COVID-19 vaccine trial results in JulyNovavax expects COVID-19 vaccine trial results in July
finance.yahoo.com - May 26 at 12:00 PM
Sanofi (EPA:SAN) Given a €103.00 Price Target by JPMorgan Chase & Co. AnalystsSanofi (EPA:SAN) Given a €103.00 Price Target by JPMorgan Chase & Co. Analysts
www.americanbankingnews.com - May 26 at 8:33 AM
Sanofi (EPA:SAN) Given a €101.00 Price Target at UBS GroupSanofi (EPA:SAN) Given a €101.00 Price Target at UBS Group
www.americanbankingnews.com - May 26 at 8:33 AM
Sanofi to shed 20.6% stake in RegeneronSanofi to shed 20.6% stake in Regeneron
seekingalpha.com - May 26 at 7:00 AM
Regeneron to buy back $5 billion stake held by SanofiRegeneron to buy back $5 billion stake held by Sanofi
www.nasdaq.com - May 26 at 7:00 AM
Regeneron launches offering of Sanofi stakeRegeneron launches offering of Sanofi stake
seekingalpha.com - May 26 at 7:00 AM
Sanofi Selling $13 Billion Regeneron Stake to Fund Drug HuntSanofi Selling $13 Billion Regeneron Stake to Fund Drug Hunt
finance.yahoo.com - May 26 at 7:00 AM
Sanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaborationSanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaboration
finance.yahoo.com - May 26 at 7:00 AM
Merck leaps into COVID-19 development fray with vaccine, drug dealsMerck leaps into COVID-19 development fray with vaccine, drug deals
finance.yahoo.com - May 26 at 7:00 AM
Sanofi Adds Firepower in Exiting $13 Billion Regeneron StakeSanofi Adds Firepower in Exiting $13 Billion Regeneron Stake
finance.yahoo.com - May 26 at 7:00 AM
Sanofi SA (EPA:SAN) Receives Average Rating of "Buy" from AnalystsSanofi SA (EPA:SAN) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - May 25 at 6:13 AM
Outlook on the Global Diabetes Disposable Insulin Delivery Pen Industry to 2026 - Major Players Analysed are Novo Nordisk, Eli Lilly & Sanofi Among Others - ResearchAndMarkets.comOutlook on the Global Diabetes Disposable Insulin Delivery Pen Industry to 2026 - Major Players Analysed are Novo Nordisk, Eli Lilly & Sanofi Among Others - ResearchAndMarkets.com
www.businesswire.com - May 23 at 7:54 PM
Some wellness products growing ‘over 1,000%’ during pandemic: Ro CEOSome wellness products growing ‘over 1,000%’ during pandemic: Ro CEO
finance.yahoo.com - May 23 at 9:41 AM
U.S. Raises Ante in Vaccine Race With $1.2 Billion for AstraU.S. Raises Ante in Vaccine Race With $1.2 Billion for Astra
finance.yahoo.com - May 21 at 2:28 PM
U.S. gives AstraZeneca $1.2 billion to fund Oxford University coronavirus vaccine, securing 300 million doses for country from OctoberU.S. gives AstraZeneca $1.2 billion to fund Oxford University coronavirus vaccine, securing 300 million doses for country from October
finance.yahoo.com - May 21 at 9:27 AM
BRIEF-Sanofi to highlight progress on various pipeline programs - ReutersBRIEF-Sanofi to highlight progress on various pipeline programs - Reuters
www.reuters.com - May 18 at 8:53 AM
Sanofi to highlight pipeline programs in a series of interactive virtual sessions leading to a R&D day event - GlobeNewswireSanofi to highlight pipeline programs in a series of interactive virtual sessions leading to a R&D day event - GlobeNewswire
www.globenewswire.com - May 18 at 8:53 AM
Sanofi CEO Sparks Outrage in France in U.S. Vaccine Row - BloombergSanofi CEO Sparks Outrage in France in U.S. Vaccine Row - Bloomberg
www.bloomberg.com - May 17 at 9:07 AM
Sanofi walks back comments to give U.S. vaccine first - Yahoo FinanceSanofi walks back comments to give U.S. vaccine first - Yahoo Finance
finance.yahoo.com - May 15 at 7:32 AM
Frances Macron to meet Sanofi chief on May 19: Elysee - ReutersFrance's Macron to meet Sanofi chief on May 19: Elysee - Reuters
www.reuters.com - May 14 at 8:43 PM
France Says ‘Unacceptable’ For U.S. to Get Sanofi Vaccine First - BloombergFrance Says ‘Unacceptable’ For U.S. to Get Sanofi Vaccine First - Bloomberg
www.bloomberg.com - May 14 at 5:40 AM
Sanofi to showcase oncology portfolio and innovative pipeline at ASCO20 Virtual Scientific Program - PRNewswireSanofi to showcase oncology portfolio and innovative pipeline at ASCO20 Virtual Scientific Program - PRNewswire
www.prnewswire.com - May 13 at 7:05 PM
Sanofi (EPA:SAN) PT Set at €106.00 by Goldman Sachs GroupSanofi (EPA:SAN) PT Set at €106.00 by Goldman Sachs Group
www.americanbankingnews.com - May 12 at 11:48 AM
Sanofi: Sarclisa Trial Meets Primary Goal Early In Relapsed Multiple Myeloma - NasdaqSanofi: Sarclisa Trial Meets Primary Goal Early In Relapsed Multiple Myeloma - Nasdaq
www.nasdaq.com - May 12 at 2:16 AM
Sarclisa® (isatuximab) Phase 3 IKEMA trial meets primary endpoint early in patients with relapsed multiple myelomaSarclisa® (isatuximab) Phase 3 IKEMA trial meets primary endpoint early in patients with relapsed multiple myeloma
finance.yahoo.com - May 12 at 2:16 AM
Sanofi (EPA:SAN) Given a €103.00 Price Target at UBS GroupSanofi (EPA:SAN) Given a €103.00 Price Target at UBS Group
www.americanbankingnews.com - May 9 at 6:41 AM
Exclusive: Sanofi to enroll thousands for its coronavirus vaccine trials - ReutersExclusive: Sanofi to enroll thousands for its coronavirus vaccine trials - Reuters
www.reuters.com - May 5 at 11:08 PM
Interleukin Inhibitors Market 2020 Research and Clinical Analysis - Sanofi, GlaxoSmithKline, Novartis, Johnson & JohnsonInterleukin Inhibitors Market 2020 Research and Clinical Analysis - Sanofi, GlaxoSmithKline, Novartis, Johnson & Johnson
www.marketwatch.com - May 5 at 8:35 AM
Oral Antidiabetic Drugs Market (COVID-19 Impact) 2020 Forecast Analysis by 2024 - Key Players : Eli Lilly, Abbott, Biocon, Sanofi, SunpharmaOral Antidiabetic Drugs Market (COVID-19 Impact) 2020 Forecast Analysis by 2024 - Key Players : Eli Lilly, Abbott, Biocon, Sanofi, Sunpharma
www.marketwatch.com - May 5 at 8:35 AM
Libtayo® (cemiplimab) shows clinically meaningful and durable responses in second-line advanced basal cell carcinoma - GlobeNewswireLibtayo® (cemiplimab) shows clinically meaningful and durable responses in second-line advanced basal cell carcinoma - GlobeNewswire
www.globenewswire.com - May 5 at 3:34 AM
This page was last updated on 6/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.